StockNews.com initiated coverage on shares of MEI Pharma (NASDAQ:MEIP – Get Rating) in a research note issued to investors on Saturday morning. The brokerage issued a hold rating on the stock. Several other research analysts have also commented on the stock. Jefferies Financial Group lowered shares of MEI Pharma from a hold rating to an […]
Shares of MEI Pharma, Inc. (NASDAQ:MEIP – Get Rating) have been assigned a consensus recommendation of “Hold” from the eight research firms that are covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month price […]
Shares of MEI Pharma, Inc. (NASDAQ:MEIP – Get Rating) have earned a consensus recommendation of “Hold” from the ten brokerages that are covering the firm, Marketbeat reports. Five equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average twelve-month price target among […]
MEI Pharma, Inc. (NASDAQ:MEIP – Get Rating) – Stock analysts at Jefferies Financial Group dropped their FY2023 EPS estimates for shares of MEI Pharma in a note issued to investors on Tuesday, May 24th. Jefferies Financial Group analyst C. Howerton now anticipates that the company will post earnings per share of ($0.75) for the year, […]
MEI Pharma (NASDAQ:MEIP – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Wednesday, Zacks.com reports. According to Zacks, “MEI Pharma, Inc. is an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism. The Company is focused on […]